5 hasil untuk "Raheem F H Al Aameri"
Menampilkan 1–5 · 0,04 detik · RSS
-
Artikel Jurnal
Role of RGS17 in cisplatin-induced cochlear inflammation and ototoxicity via caspase-3 activation
Cisplatin is a chemotherapy drug used to treat different solid tumors, including ovarian, bladder, lung, and head and neck cancers. One of its significant side effects is ototoxicity, especially when high doses are required. Cisplatin-induced ototoxicity is associated with increased cochlear cell…
-
Artikel Jurnal
Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss
Abstract Regulators of G protein signaling (RGS) accelerate the GTPase activity of G proteins to enable rapid termination of the signals triggered by G protein-coupled receptors (GPCRs). Activation of several GPCRs, including cannabinoid receptor 2 (CB2R) and adenosine A1 receptor (A1AR), protects…
-
Artikel Jurnal Teks lengkap
Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrol.
Prostate cancer (PCa) is the second leading cause of cancer deaths in men. A better understanding of the molecular basis of prostate cancer proliferation and metastasis should enable development of more effective treatments. In this study we focused on the lncRNA, prostate cancer associated…
-
Artikel Jurnal
Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity
Cisplatin is chemotherapy used for solid tumor treatment like lung, bladder, head and neck, ovarian and testicular cancers. However, cisplatin-induced ototoxicity limits the utility of this agent in cancer patients, especially when dose escalations are needed. Ototoxicity is associated with…